Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.23
+0.06 (0.97%)
Jun 8, 2026, 4:00 PM EDT - Market closed
Silence Therapeutics Employees
Silence Therapeutics had 88 employees as of December 31, 2025. The number of employees decreased by 28 or -24.14% compared to the previous year.
Employees
88
Change (1Y)
-28
Growth (1Y)
-24.14%
Revenue / Employee
$9,534
Profits / Employee
-$852,716
Market Cap
294.27M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 88 | -28 | -24.14% |
| Dec 31, 2024 | 116 | 7 | 6.42% |
| Dec 31, 2023 | 109 | -13 | -10.66% |
| Dec 31, 2022 | 122 | 17 | 16.19% |
| Dec 31, 2021 | 105 | 40 | 61.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Rocket Pharmaceuticals | 202 |
| Humacyte | 184 |
| Nautilus Biotechnology | 127 |
| Invivyd | 122 |
| Neumora Therapeutics | 96 |
| Lineage Cell Therapeutics | 77 |
| Fennec Pharmaceuticals | 35 |
SLN News
- 5 days ago - Silence Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 12 days ago - Silence Therapeutics to Participate in Jefferies Global Healthcare Conference - Business Wire
- 20 days ago - Silence Therapeutics Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 21 days ago - Silence Therapeutics Registration statement: Registration filing - Filings
- 27 days ago - Silence Therapeutics to Participate in H.C. Wainwright BioConnect Investor Conference - Business Wire
- 4 weeks ago - Silence Therapeutics Highlights Recent Business Achievements and Reports First Quarter 2026 Financial Results - Business Wire
- 4 weeks ago - Silence Therapeutics Earnings release: Q1 2026 - Filings
- 4 weeks ago - Silence Therapeutics Quarterly report: Q1 2026 - Filings